Long non-coding RNAS: Molecular functions, mechanisms, and clinical implications
Abstract
Long non-coding RNAs (lncRNAs) have emerged as a major class of regulatory RNA molecules with crucial roles in gene regulation, development, and disease. Although they lack protein-coding potential, lncRNAs account for a significant proportion of the mammalian transcriptome and exhibit remarkable tissue, developmental stage, and cell-type specificity. Advances in large-scale genome and transcriptome projects have overturned the notion of “junk DNA,” revealing that lncRNAs participate in diverse biological processes, including chromatin remodeling, transcriptional and post-transcriptional regulation, genomic imprinting, X-chromosome inactivation, and cellular differentiation. This review provides a comprehensive overview of the molecular characteristics, structural features, classification, and functional mechanisms of lncRNAs. Special emphasis is placed on their involvement in normal development, epigenetic regulation, and pathological conditions, particularly cancer. The emerging role of lncRNAs as diagnostic, prognostic, and therapeutic biomarkers is discussed, including their detection in circulating body fluids and their relevance in veterinary oncology such as horn cancer in cattle. Finally, current challenges and future prospects in lncRNA research are highlighted, underscoring their potential as novel targets for epigenetic intervention and precision medicine in both human and animal health.
Full Text
Tables and figures are in the full-text PDF.
Introduction
Large-scale genome projects have revealed that regions once dismissed as "junk DNA" actually perform important regulatory functions. Although the human genome contains only about 20,000 protein-coding genes that is less than 2% of total DNA. This suggests that organismal complexity cannot be explained by protein-coding genes alone and is instead influenced by processes like RNA splicing and post-translational modification. Systematic transcript mapping identified thousands of non-coding RNAs, including ~35,000 non-coding transcripts described by the FANTOM project. These non-coding RNAs are broadly classified as small ncRNAs and long non-coding RNAs (LncRNAs). The small ncRNAs are represented by a broad range of known and newly discovered RNA species, with many being associated with 5' or 3' regions of genes. Whereas, LncRNAs are defined as a heterogeneous group of transcripts ranging in length from 200 nt to ~100 kb, lacking significant Open Reading Frames (ORF), do not exhibit coding potential, transcribed by RNA polymerase II, undergo posttranscriptional processing such as alternative splicing, 5′ capping, polyadenylation, RNA editing and also carry Single Nucleotide Polymorphisms (SNPs) (Jarroux et al., 2017) [9] .
The structure of LncRNA RNA is a very flexible and dynamic molecule that forms complex secondary structures. The structure of LncRNA defines its cellular degradation and its functional versatility, allowing it to set up its subcellular location and form interactions with protein complexes. An increasing number of examples show that the secondary structure of LncRNA constitutes the main primary functional unit, thus bypassing the absence of evolutionary constraints (no code for proteins) and their poor sequence conservation between living species. HOTAIR is the most studied example, characterized only in mammals, and sharing only 58% homology between mice and men (Bhan and Mandal, 2015) [3] , but with a conserved function of epigenetic regulation of chromatin domains.
Characteristics of LncRNAs
LncRNAs are typically characterized by features similar to messenger RNAs, including 5′ capping, 3′ polyadenylation, multiple exons, transcriptional activation and splicing and they are predominantly transcribed by RNA polymerase II. However, unlike mRNAs, they generally lack clear Open Reading Frames (ORFs) and do not always undergo standard mRNA-processing pathways. LncRNAs are widely conserved across a broad range of organisms, including animals, plants, yeast, prokaryotes, and even viruses. It is estimated that up to 80% of transcription in mammalian genomes is associated with LncRNAs. Moreover, LncRNAs exhibit striking biological specificity, showing approximately 78% tissue, developmental-stage and cell-subtype specificity, which is much higher than that observed for mRNAs, where only about 19% demonstrate comparable specificity (Yan et al., 2013) [18] .
Functions of LncRNA
LncRNAs perform a wide variety of regulatory and cellular functions. They are involved in controlling transcription, splicing and translation and can influence protein localization and the maintenance of cellular structural integrity. LncRNAs also participate in genomic imprinting, regulation of apoptosis, maintenance of stem cell pluripotency and cellular reprogramming. Many LncRNAs play key roles in cancer progression and can act as precursors for small RNAs, including endogenous siRNAs. Because of these diverse activities, LncRNAs are increasingly recognized as important contributors to the development and progression of numerous human and animal diseases.
Classification of LncRNA
Classification methods of LncRNAs according to their different features 1) Genome location and context 2) Exerted effect on DNA sequences 3) Mechanism of functioning and 4) Targeting mechanism (Ma et al., 2013) [14] 1. Based on genomic location & context a) Intergenic vs intronic: Intergenic long non-coding RNAs (lincRNAs) are located between protein-coding genes and are well-studied; they are often conserved and exhibit tissue-specific expression. In contrast, intronic LncRNAs are transcribed from the introns of proteincoding genes, and relatively few of them have been functionally characterized. b) Sense vs antisense: Sense LncRNAs are transcribed from the same strand as protein-coding genes and may partially or completely overlap with them. In contrast, antisense LncRNAs are transcribed from the opposite strand and commonly regulate ther paired coding genes.
Based on effects
Based on targeting mechanism
Based on their targeting mechanism, LncRNAs can function in several ways. Some act as signals, being expressed under specific conditions, as exemplified by Xist and COLDAIR. Others function as decoys, binding to and sequestering proteins, such as PANDA. Certain LncRNAs serve as guides, directing protein complexes to specific DNA regions, with HOTAIR being a well-known example. Finally, some LncRNAs act as scaffolds, bringing multiple proteins together to form functional complexes, as seen with HOTAIR and 7SL.
Involvement of LncRNA in development X-chromosome inactivation
In therian mammals, females possess two X chromosomes whereas males have only one, creating the need to balance X-linked gene expression between the sexes. This balance is achieved through X-Chromosome Inactivation (XCI), a process in which one X chromosome in females becomes transcriptionally silenced (Lyon, 1961) [13] . In placental mammals, XCI occurs as imprinted XCI, where the paternal X chromosome is preferentially silenced in early embryonic and extra-embryonic tissues, and random XCI, in which either the maternal or paternal X chromosome is inactivated in embryonic cells, resulting in mosaic expression patterns in females. The process is regulated by the X-inactivation center (Xic), which encodes several LncRNAs, most notably Xist.
Xist is expressed exclusively from the chromosome that will become inactive and spreads along it to form an RNA "coat," thereby recruiting chromatin-modifying complexes such as PRC2 to establish transcriptional silencing.
The regulation of Xist itself involves additional LncRNAs. Tsix, which is transcribed antisense to Xist, represses Xist expression prior to X-chromosome inactivation, thereby helping determine which X chromosome remains active. Conversely, Jpx functions as an activator of Xist in trans by displacing the transcriptional repressor CTCF from the Xist promoter region. Together, these coordinated regulatory mechanisms ensure the correct initiation, spreading and maintenance of X-chromosome inactivation, establishing a classical paradigm for RNA-mediated epigenetic regulation.
Regulation of allelic expression: Genomic imprinting
Genomic imprinting is a form of epigenetic regulation in which certain genes are expressed in a parent-of-originspecific manner, resulting in monoallelic expression of either the maternal or paternal allele. Similar to X-chromosome inactivation, imprinting is governed by Imprinting Control Regions (ICRs), many of which transcribe LncRNAs that regulate neighboring protein-coding genes. One of the earliest and most abundant embryonic LncRNAs identified was H19, which is reciprocally imprinted with Igf2 and additionally functions as a precursor for several microRNAs. Imprinted genes are essential for fetal growth, metabolic regulation and postnatal behavior, and they typically occur in ~1 Mb clusters controlled by ICRs, where either the maternal or paternal allele is selectively expressed (Barlow, 2011) [1] . Two principal mechanisms operate within these clusters: the insulator model, classically represented by the H19/Igf2 locus, and the more prevalent LncRNA-mediated model, exemplified by the Igf2r/Airn locus. Together, these observations highlight LncRNAs as key regulators of parental allele-specific gene expression and epigenetic inheritance.
Involvement of LncRNAs in normal development
LncRNAs play critical roles in regulating normal development by modulating gene expression programs, particularly within the Hox gene clusters. The LncRNA HOTAIR, transcribed from an intergenic region within the human HOXC cluster, represses genes in the HOXD cluster in trans, thereby influencing the anterior-posterior patterning of the embryo (Rinn et al., 2007) [15] . Hox genes encode transcription factors that determine the identity of embryonic segments and the type of structures that form on them, such as vertebrae in humans or legs and wings in fruit flies. During development, Hox gene expression is controlled by LncRNAs through chromatin modifications and changes in chromosome architecture. For example, the LncRNAs Hotdog (Hog) and Twin of Hotdog (Tog), located near the HoxD locus and transcribed from opposite strands, are specifically expressed in the caecum and physically associate with HoxD genes to regulate their expression. Disruption of Hog or Tog expression abolishes HoxD activity in the caecum, demonstrating that these physical LncRNA-gene interactions are essential for proper spatial regulation of HoxD genes during organ development (Delpretti et al., 2013) [5] .
Homeotic transformation
The long non-coding RNA HOTAIR was the first LncRNA reported to silence genes in trans, particularly the HOXD cluster (Rinn et al., 2007) [15] . Knockout of Hotair in mice leads to derepression of multiple target genes, including Hoxd10 and Hoxd11, which are critical for the patterning of the lumbosacral junction and the metacarpal and carpal bones in the limbs. This misregulation contributes to homeotic transformations of the axial skeleton observed in Hotair knockout mice (Li et al., 2013) [11] . Genome-wide studies using RNA sequencing and conditional inactivation have shown that Hotair is also required to repress additional HoxD genes as well as several imprinted loci, including Dlk1-Meg3 and Igf2-H19, without altering imprinting choice. Mechanistically, Hotair functions by binding both the PRC2, which catalyzes histone H3 lysine 27 trimethylation (H3K27me3), and the Lsd1 complex, which demethylates histone H3 lysine 4 (H3K4), thereby establishing a repressive chromatin state. Loss of Hotair results in gain of H3K4 trimethylation (H3K4me3) and a partial loss of H3K27me3 at target loci, demonstrating its key role in maintaining transcriptional silencing of Hox and other developmentally important genes (Zhao et al., 2010) [20] .
Role of LncRNAs in diseases
LncRNAs are RNAs with some special features, such as higher tissue-specificity, higher stage specificity and higher cell subtype specificity, and therefore their expression markers could be used for biomarkers of diagnostics and classification in tumor diseases and tumorigenesis.
LncRNAs biomarkers for tumor prediction
LncRNAs have emerged as promising biomarkers for tumor prediction due to their aberrant expression in various cancers. RNA FISH techniques are increasingly used to detect these changes, with PCA3 and PCAT1 being commonly studied in prostate cancer, GAS5 in breast cancer, and UCA1 is showing downregulation in bladder cancer (Eissa et al., 2015) [6] . Exon microarray analyses across thirteen different cancers, including prostate, breast, and bladder cancers, further support the utility of LncRNA detection via FISH (Gupta and Tripathi, 2017) [7] . Given the heterogeneity of cancer, LncRNAs often display subtype-specific expression, such as MIAT in the mesenchymal subtype of ovarian cancer and RMST in rhabdomyosarcoma, highlighting their potential in distinguishing individual tumor subtypes. However, these findings require further validation using RNA FISH and qRT-PCR to confirm subtype-specific expression patterns.
LncRNAs biomarkers for tumor prognosis
According to recent clinical assays, several LncRNAs increase and decrease have been demonstrated in some special tumors. For example, up-expressed HOTAIR, HOTTIP, DANCR and CCAT1 are related with poor survival from colon cancer patients (Luo et al., 2016) [12] . Some LncRNAs such as RP1, RP4, RP11 and RP13 profiles are going to be used to study tumor prognosis with up-expressed and down expression in breast. [10] . However, further confirmation is needed to clearly establish their roles as cancer-causing drivers.
LncRNAs in horn cancer
Horn Cancer (HC) is a common tumor of the horn core epithelium in working cattle, especially castrated bullocks (≈95% of cases), with fewer cases in cows and rare cases in other livestock (Gupta et al., 1980) [8] . LncRNAs generally show low expression and high tissue specificity, making them promising prognostic and therapeutic biomarkers (Batista and Chang, 2013) [2] . LncRNAs are already known to play important regulatory roles in bovine development (Yang et al., 2018) [19] and their involvement in human cancers has guided research into HC (Chiu et al., 2018) [4] . Using Illumina paired-end sequencing, Sabara et al. (2019) [16] identified seven upregulated and one downregulated LncRNAs associated with keratin-related and other cancerlinked genes involved in cell growth, invasion, migration, and communication.
Clinical challenge for application
Aberrantly expressed LncRNAs) in tumors offer important opportunities for cancer diagnosis and therapy. Because LncRNAs show highly specific expression patterns and can be detected in body fluids, they have strong potential for accurate clinical diagnostics. However, current applications are limited by uncertainty over whether abnormal LncRNA expression is a cause or consequence of cancer. Although several companies are developing LncRNA-based therapies (Sánchez and Huarte, 2013) [17] , major challenges remain.
Future prospects
There is a need for large-scale gain-of-function studies to causally demonstrate LncRNA functions. There is a clear need to develop genetic model systems to understand LncRNAs' function in vivo. Use of siRNA to target diseasesassociated LncRNAs for therapeutic purpose. They can act as novel epigenetic intervention tools for specific sites within the genome. The LncRNAs will provide new answer to old questions of evolution and development.
References
- Barlow DP. Genomic imprinting: A mammalian epigenetic discovery model. Annu Rev Genet. 2011;45:379-403.
- Batista PJ, Chang HY. Long noncoding RNAs: Cellular address codes in development and disease. Cell. 2013;152(6):1298-1307.
- Bhan A, Mandal SS. LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer. Biochim Biophys Acta. 2015;1856:151-164.
- Chiu HS, Somvanshi S, Patel E, Chen TW, Singh VP, Zorman B, et al. Pan-cancer analysis of lncRNA regulation supports their targeting of cancer genes in each tumor context. Cell Rep. 2018;23(1):297-312.
- Delpretti S, Montavon T, Leleu M, Joye E, Tzika A, Milinkovitch M, et al. Multiple enhancers regulate Hoxd genes and the Hotdog lncRNA during cecum budding. Cell Rep. 2013;5(1):137-150.
- Eissa S, Matboli M, Essawy NO, Shehta M, Kotb YM. Rapid detection of urinary long non-coding RNA urothelial carcinoma associated one using a PCR-free nanoparticle-based assay. Biomarkers. 2015;20(3):212217.
- Gupta SC, Tripathi YN. Potential of long non-coding RNAs in cancer patients: from biomarkers to therapeutic targets. Int J Cancer. 2017;140(9):1955-1967.
- Gupta RK, Sadana JR, Kuchroo VK, Kalra DS. Horn cancer in an intact bull. Indian Vet J. 1980;57.
- Jeong S, Lee J, Kim D, Seol MY, Lee WK, Jeong JJ, et al. Relationship of focally amplified long noncoding RNA on chromosome 1 (FAL1) with E2F transcription factors in thyroid cancer. Medicine (Baltimore). 2016;95(4):e2592.
- Li L, Liu B, Wapinski OL, Tsai MC, Qu K, Zhang J, et al. Targeted disruption of Hotair leads to homeotic transformation and gene derepression. Cell Rep. 2013;5(1):3-12.
- Luo ZF, Zhao D, Li XQ, Cui YX, Ma N, Lu CX, et al. Clinical significance of HOTAIR expression in colon cancer. World J Gastroenterol. 2016;22(22):5254-5263.
- Lyon MF. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature. 1961;190(4773):372373.
- Ma L, Bajic VB, Zhang Z. On the classification of long non-coding RNAs. RNA Biol. 2013;10(6):924-933.
- Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007;129(7):1311-1323.
- Sabara PH, Jakhesara SJ, Panchal KJ, Joshi CG, Koringa PG. Transcriptomic analysis to affirm the regulatory role of long non-coding RNA in horn cancer of Indian zebu cattle breed Kankrej (Bos indicus). Funct Integr Genomics. 2019;19:1-13.
- Sánchez Y, Huarte M. Long non-coding RNAs: challenges for diagnosis and therapies. Nucleic Acid Ther. 2013;23(1):15-20.
- Yan L, Yang M, Guo H, Yang L, Wu J, Li R, et al. Single-cell RNA-Seq profiling of human preimplantation embryos and embryonic stem cells. Nat Struct Mol Biol. 2013;20(9):1131-1139.
- Yang B, Jiao B, Ge W, Zhang X, Wang S, Zhao H, et al. Transcriptome sequencing to detect the potential role of long non-coding RNAs in bovine mammary gland during the dry and lactation period. BMC Genomics. 2018;19(1):605.
- Zhao J, Ohsumi TK, Kung JT, Ogawa Y, Grau DJ, Sarma K, et al. Genome-wide identification of polycombassociated RNAs by RIP-seq. Mol Cell. 2010;40(6):939953.
How this paper connects to the literature. Drag to explore, click any node to open that paper.
